F63.3 F63.8 F63.9 F98.8
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: consent to participate in study (informed consent); internet access; sufficient command of the German language; willingness to participate in two anonymous online surveys, each of which lasts approx. 25-30 minutes; willingness to participate in a 6-week training program; willingness to use the program on one's own responsibility; willingness to provide an e-mail address
Exclusion criteria
Exclusion criteria: lifetime schizophrenia; acute suicidal tendencies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total score of the the Generic Body-Focused Repetitive Behavior Scale 36 (GBS-36) after the six-week intervention period (t0, t1). | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient Health Questionnaire-9 (PHQ-9): Self-rating questionnaire measuring depressive symptoms during the past week (t0, t1, t2). Quality of life (WHO-QOL-BREF): Questionnaire that measures the quality of life in the last two weeks (t0, t1, t2). Questionnaire on patient satisfaction in modified version (ZUF-8): Self-report questionnaire that measures the global patient satisfaction at the end of treatment (t1, t2). Questionnaire for subjective evaluation (t1, t2). Milwaukee Inventory for Subtypes of Trichotillomania-Adult Version (MIST-A): Self-report questionnaire that measures "automatic pulling" vs. "focused pulling” behavior (t0, t1, t2). | — |
Countries
Austria, Germany, Switzerland
Contacts
Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Arbeitsgruppe Klinische Neuropsychologie